Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 1 |
2018 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Unknown field was ignored: [18F]
Page 1
Assessment of the Incremental Diagnostic Value of Florbetapir F 18 Imaging in Patients With Cognitive Impairment: The Incremental Diagnostic Value of Amyloid PET With [18F]-Florbetapir (INDIA-FBP) Study.
JAMA Neurol. 2016 Dec 1;73(12):1417-1424. doi: 10.1001/jamaneurol.2016.3751.
JAMA Neurol. 2016.
PMID: 27802513
OBJECTIVE: To evaluate the incremental diagnostic value of amyloid PET with florbetapir F 18 in addition to the routine clinical diagnostic assessment of patients evaluated for cognitive impairment. ...Diagnostic confidence in AD …
OBJECTIVE: To evaluate the incremental diagnostic value of amyloid PET with florbetapir F 18 in addition …
Quantitative appraisal of the Amyloid Imaging Taskforce appropriate use criteria for amyloid-PET.
Altomare D, Ferrari C, Festari C, Guerra UP, Muscio C, Padovani A, Frisoni GB, Boccardi M; Incremental Diagnostic Value of Amyloid PET With [(18)F]-Florbetapir (INDIA-FBP) Working Group.
Altomare D, et al.
Alzheimers Dement. 2018 Aug;14(8):1088-1098. doi: 10.1016/j.jalz.2018.02.022. Epub 2018 Apr 19.
Alzheimers Dement. 2018.
PMID: 29679576
INTRODUCTION: We test the hypothesis that amyloid-positron emission tomography prescriptions, considered appropriate based on the Amyloid Imaging Taskforce (AIT) criteria, lead to greater clinical utility than AIT-inappropriate prescriptions. METHODS: We compared th …
INTRODUCTION: We test the hypothesis that amyloid-positron emission tomography prescriptions, considered appropriate based on the …
Item in Clipboard
Cite
Cite